FDA inspection
Boehringer Ingelheim Pharmaceuticals, Inc.: FDA inspection ending Dec 12, 2019
FDA inspection 1112627 · Voluntary Action Indicated (VAI) · Ridgefield, CT
Key facts
| Inspection ID | 1112627 |
|---|---|
| Firm | Boehringer Ingelheim Pharmaceuticals, Inc. |
| FEI number | 1219205 |
| Address | 900 Ridgebury Rd |
| City | Ridgefield |
| State | CT |
| ZIP | 06877 |
| Country | United States |
| Fiscal year | 2020 |
| Inspection end date | Dec 12, 2019 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data